Hester Biosciences informs about press release

28 Oct 2021 Evaluate
Hester Biosciences has informed that it enclosed press release titled 'Hester Biosciences Limited Q2 and H1 FY22 Results- Revenue up by 6% and 24%, Net Profit up by 16% and 35%, for Q2 and H1 FY22 - Appointment of additional Directors on the Board'.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×